SNCA and Parkinson disease: The literature suggests hearing measurement as a non-invasive potential biomarker and indicator of disease severity for PD, widespread alpha-synuclein neuropathology, and loss of dopaminergic neurons were suspected of interfering with such auditory dysfunction, and PD mouse models should be applied for precise assessment of hearing function and pathological mechanism exploration.